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Abstract
Background: Highly repetitive nucleotide sequences are commonly found in nature e.g. in telomeres, microsatellite
DNA, polyadenine (poly(A)) tails of eukaryotic messenger RNA as well as in several inherited human disorders linked to
trinucleotide repeat expansions in the genome. Therefore, studying repetitive sequences is of biological, biotechnological
and medical relevance. However, cloning of such repetitive DNA sequences is challenging because specific PCR-based
amplification is hampered by the lack of unique primer binding sites resulting in unspecific products.
Results: For the PCR-free generation of repetitive DNA sequences we used antiparallel oligonucleotides flanked by
restriction sites of Type IIS endonucleases. The arrangement of recognition sites allowed for stepwise and seamless
elongation of repetitive sequences. This facilitated the assembly of repetitive DNA segments and open reading
frames encoding polypeptides with periodic amino acid sequences of any desired length. By this strategy we
cloned a series of polyglutamine encoding sequences as well as highly repetitive polyadenine tracts. Such
repetitive sequences can be used for diverse biotechnological applications. As an example, the polyglutamine
sequences were expressed as His6-SUMO fusion proteins in Escherichia coli cells to study their aggregation behavior
in vitro. The His6-SUMO moiety enabled affinity purification of the polyglutamine proteins, increased their solubility,
and allowed controlled induction of the aggregation process. We successfully purified the fusions proteins and
provide an example for their applicability in filter retardation assays.
Conclusion: Our seamless cloning strategy is PCR-free and allows the directed and efficient generation of highly
repetitive DNA sequences of defined lengths by simple standard cloning procedures.
Background
Expansions of DNA repeat sequences are associated with
many inherited neurodegenerative diseases [1-3]. One of
the best-studied examples for a trinucleotide expansion
disease is the neurological disorder Huntington’s chorea,
where the accumulation of CAG triplets within the first
exon of the gene encoding the Huntingtin (Htt) protein
leads to an elongated polyglutamine (Poly-Q) stretch in
the polypeptide. It has been shown that more than 36
consecutive glutamine residues are pathogenic as they
promote Htt aggregation into amyloid-like fibrils [4]. The
translation product of the first exon of the htt gene was
previously used to study the aggregation behavior of
Poly-Q proteins in vitro [5]. In order to investigate the
influence of the length of the Poly-Q stretch on aggrega-
tion kinetics, we wanted to clone reporter constructs
containing defined numbers of glutamine residues. We
developed a PCR-free cloning strategy allowing us to cre-
ate repetitive DNA sequences encoding glutamine
stretches of defined length. These sequences were used
to generate improved constructs for filter retardation
assays to study Huntingtin aggregation in vitro.
Several methods have been described for cloning long
DNA repeat tracts. However, most of them include PCR-
based amplification steps, generate imperfect repeats, or
result in a pool of clones that differ in the number of
repeats [6-13]. As a consequence, additional effort is
required to identify and isolate clones with the desired
length of nucleotide repeats. Therefore, we developed a
simple multi-cycle cloning strategy using synthetic oligo-
nucleotides and Type IIS restriction endonucleases to
engineer highly repetitive DNA fragments. Our approach
is PCR-free and generates exclusively clones carrying the
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over, it is not only suitable to multiply the length of exist-
ing repetitive sequences but also to vary the number of
inserted repeats in every elongation cycle. Finally, we can
easily recombine constructs of the same or different
repeat lengths to accelerate the construction of the
desired number of repeats.
Results and discussion
Type IIS restriction endonucleases cut DNA at defined
distances outside their recognition site [14]. Thus, these
enzymes allow the generation of single-stranded DNA
overhangs of any desired sequence. The arrangement of
inward facing Type IIS recognition sites at the ends of
DNA fragments facilitates their fusion without incorpora-
tion of extraneous nucleotides. Therefore, such enzymes
are widely used in DNA shuffling or seamless cloning
strategies to construct synthetic genes and artificial pro-
tein polymers [15-19]. Based on this approach, we
designed double-stranded oligonucleotides containing a
defined number of central glutamine-encoding CAG and
CAA triplets (Q-block) arranged in a non-regular fashion
(Figure 1A). We decided on this approach because it has
been shown previously that interruption of perfect CAG
repeats by CAA triplets improves the stability of Poly-Q
encoding sequences in E. coli [12]. The central triplet
repeats were flanked by non-repetitive sequences that
have two important functions: First, they ensure the spe-
cific annealing of the oligonucleotides, and secondly, they
comprise two inward directed Type IIS restriction sites
(BsaI and BsmBI) and a Type IIP restriction site (SacI).
The Type IIS sites were designed to result in cuts within
the repetitive sequence and to produce compatible DNA
overhangs allowing for seamless elongation of the Poly-Q
encoding sequence (Figure 1A and 1B). In our strategy,
the BsaI and SacI restriction sites of the Q-block oligonu-
cleotides are used to elongate a pre-existing Q-block on a
plasmid digested with BsmBI and SacI (Figure 1C, lower
panel). Importantly, the inward facing BsmBI site on the
last introduced oligonucleotide remains intact upon liga-
tion and is available for further insertions. Therefore,
seamless elongation is based on the re-introduction of a
unique Type IIS site in each elongation step (Figure 1B
and 1C).
The antiparallel Q-block oligonucleotides described
above were commercially synthesized, annealed, and sub-
cloned via the BsaI and SacI restriction sites into a vector
containing a unique BsaI site (Figure 1B and 1C). The
following elongation steps of the Poly-Q encoding
sequence only require the double-stranded oligonucleo-
tides treated with the appropriate enzymes as described
above and a cloning vector without BsmBI sites. Hence,
we performed the elongation cycles in the plasmid pMK1
from which all BsmBI sites were removed by site-directed
mutagenesis. The initial introduction of the subcloned
Q-block fragment into pMK1 resulted in the plasmid
pMK1-Q11 (Figure 1C, upper panel). As a consequence,
this vector now contains a single BsmBI site downstream
of the glutamine-encoding triplets, which could be used
for the further elongation of the Q-block (Figure 1C).
Next, pMK1-Q11 was digested with the enzymes BsmBI
and SacI. The resulting cohesive ends were compatible
with the overhangs of the double-stranded Q-block oligo-
nucleotides cut by BsaI and SacI (Figure 1C). Ligation
of the insert with pMK1-Q11 gave rise to pMK1-Q20.
Thereby a unique BsmBI site was re-introduced down-
stream of the elongated Poly-Q encoding region (Figure
1C). As the cohesive ends of the annealed and digested
oligonucleotides are only compatible with the doubly-cut
plasmid, multiple insertions were efficiently prevented.
Using this strategy the directed elongation of the Q-block
was achieved by repeated cycles of digestion and ligation.
Our approach has several additional advantages beyond
providing a strategy for the directed elongation of repeti-
tive DNA sequences. An important aspect is that the num-
ber of introduced nucleotides can be adjusted precisely in
each round by defining the length of the Q-block of the
synthetic oligonucleotides (Figure 1A). Furthermore, the
generation of long repetitive sequences can be accelerated
by simple modifications (Figure 2). For example, pMK1-
Q20 was digested with BsaI and SacI and the resulting
Q-block fragment was ligated with the pMK1-Q20 back-
bone cleaved with BsmBI and SacI. This slight adaptation
of the protocol enabled the formation of pMK1-Q38 and
demonstrates that the numbero fQ - e n c o d i n gt r i p l e t s
could be rapidly increased in a single step. This allowed
the fast generation of a pool of constructs with different
lengths of the repetitive sequences that can be easily
recombined (Figure 3A). Figure 3B shows the restriction
digestion analysis of the constructed pMK1-Qn plasmids
carrying inserts encoding the indicated Poly-Q stretches.
Our approach is also suitable to increase the length of
repetitive sequences by multiple insertions as described
previously [13]. Thereby, simultaneous digestion of the
annealed oligonucleotides or pMK1-Qn plasmids with
both Type IIS restriction enzymes would result in Q-block
fragments with compatible overhangs (Figure 1A). This
would allow for ligation of multiple Q-blocks in a single
step.
Importantly, our technique is not limited to generate
Poly-Q encoding sequences but can also be used for other
nucleotide repeats. One example of highly repetitive
nucleotide sequences are the poly(A) tails attached to the
3’ ends of eukaryotic mRNAs by poly(A)-polymerases.
These poly(A) extensions are up to 250 nucleotides in
length and they are important for mRNA stability and effi-
cient translation initiation [20]. As polyadenylation is lack-
ing in conventional in vitro transcription reactions, poly
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Figure 1 Cloning strategy of Poly-Q encoding sequences.( A) Annealed oligonucleotides used for cloning of the Poly-Q encoding regions.
The recognition sequences and the corresponding cleavage sites of the restriction endonucleases are indicated by different colors. The
orientation of the two inward facing Type IIS restriction sites (BsaI and BsmBI) results in cleavage within the Poly-Q encoding sequence and
allows seamless elongation of the Poly-Q stretch. (B) Detailed representation of the elongation cycles. Digestion of the double-stranded
oligonucleotides (BsaI/SacI) and the vector (BsmBI/SacI) resulted in compatible overhangs allowing for seamless elongation. Used restriction sites
are underlined. (C) The annealed oligonucleotides were initially subcloned using BsaI and SacI and subsequently inserted into pMK1 via NdeI and
SacI. For further elongation BsaI/SacI digested oligonucleotides were ligated into pMK1-Qn digested with BsmBI and SacI. Thereby the number of
Q-encoding nucleotides was increased by nine and a new BsmBI site was introduced allowing subsequent rounds of elongation.
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Page 3 of 9(A) fragments are usually fused to the 3’ untranslated
regions of the DNA templates. Nevertheless, controlling
the length of the poly(A) sequence is difficult to achieve
by conventional cloning strategies. We have successfully
applied our novel approach for the directed elongation of
repetitive DNA sequences to create poly(A) stretches of
defined length in DNA templates for the in vitro produc-
tion of polyadenylated mRNA (Figure 4). Therefore, we
used A-block oligonucleotides instead of Q-blocks and
applied the same basic strategy as described above. In this
case we used two oligonucleotide pairs (A31 and A32)t o
generate a stretch of 57 adenines and an inward facing
BsmBI site in a single initiation step (Figure 4A and 4B).
The newly introduced BsmBI site was used to elongate the
poly(A) region with the oligonucleotide pair A32 (Figure
4A, lower panel). A restriction digestion analysis of the
initiation and elongation steps of poly(A) cloning is shown
in Figure 4C.
Theoretically, the basic strategy can also be expanded
to establish a modular system of double-stranded DNA
oligonucleotides or PCR-amplified fragments carrying
different sequences that can be fused in a directed fash-
ion and in any desired order. This is possible as long as
the recognition sites of the Type IIS enzymes are
designed to produce compatible ends (Figure 5). More-
over, other combinations of Type IIS and Type IIP
restriction endonucleases can be used instead of the
ones chosen in this study.
Our initial intention was to generate Poly-Q constructs
for in vitro experiments. So far, we cloned repetitive
DNA sequences of different lengths encoding Poly-Q
stretches between 11 and 218 residues into the pMK1
vector (Figure 3A). We next adopted these constructs to
meet our specific purposes. In our final constructs the 17
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accelerated. The elongation of the Q-encoding region was
accelerated by a simple modification of the cloning strategy. For
example, the Poly-Q encoding region of the plasmid pMK1-Q20 can
be excised with BsaI and SacI and ligated into the same vector
digested with BsmBI/SacI. Thereby, the number of Q-encoding
repeats can be almost doubled in a single cloning step.
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Figure 3 Overview of the seamless cloning of repetitive
sequences for the production of Poly-Q proteins.( A) Genealogy
of the pMK1-vectors. A pool of different pMK1 vectors was
generated by elongation cycles using double-stranded
oligonucleotides or Poly-Q encoding DNA fragments derived from
pre-existing pMK1-Qn vectors. (B) Repetitive sequences of different
lengths cloned by the described strategy in (A). pMK1-Qn plasmids
encoding indicated Poly-Q stretches were digested with EcoRI (cuts
77 bp upstream of BsaI) and SacI. The inserts were separated on a
2% agarose gel and visualized by ethidium bromide (EtBr) staining.
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Page 4 of 9N-terminal amino acids of Htt (N17) flank the different
Poly-Q regions and a FLAG-tag for immunodetection is
located at the C-terminal end. In order to insert the var-
ious Q-blocks between the N17 and FLAG-tag encoding
sequences on the expression vector (pLANA), the
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Figure 4 Cloning of poly(A) constructs.( A)O u rb a s i cs t r a t e g y
was also successfully applied to the cloning of adenine repeat
sequences. Here two antiparallel oligonucleotide pairs that differ in
their restriction sites and length of the poly(A) region, A31 and A32,
were used for the initiation step. A31,A 32, and pMK0 were digested
with HindIII/BsaI, BsaI/XhoI, and HindIII/XhoI, respectively, and
ligated in a single reaction to obtain pMK0-A57. For elongation the
BsaI/XhoI digested oligonucleotide A32 was inserted into pMK0-A57
cut with BsmBI and XhoI. The elongation principle is the same as
described above for the Poly-Q constructs. Used restriction sites are
underlined. (B) Antiparallel oligonucleotide pairs used for cloning of
the poly(A) sequences. The recognition sequences and the
corresponding cleavage sites of the restriction endonucleases are
indicated by different colors. The inward facing BsaI sites on A31
and A32 were designed in a way to allow the seamless fusion of the
oligonucleotides via their A-blocks. (C) Initiation and elongation step
of poly(A) cloning. pMK0-An plasmids containing the indicated
number of adenines or the empty pMK0 vector were digested with
SacI (cuts 199 bp upstream of poly(A)) and XhoI. The inserts were
separated on a 10% polyacrylamide (PAA) gel and visualized by
ethidium bromide (EtBr) staining.
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Figure 5 Strategy to combine different repetitive sequences in
a modular fashion. Antiparallel oligonucleotide pairs with different
repetitive sequences (orange and blue) can be fused on one
plasmid if their Type IIS recognition sites (IIS) are designed in a way
that they create compatible overhangs. Moreover, our strategy is
not restricted to specific endonucleases. The use of any
combination of one Type IIP (IIP) and two different compatible Type
IIS enzymes is possible. Upon insertion of the first annealed and
digested oligonucleotide pair (orange) via IIS and IIP, the resulting
vector can be digested with IIS’ and IIP to allow the incorporation
of a second double-stranded oligonucleotide pair (blue).
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Page 5 of 9plasmid was linearized with the BsaI enzyme. The gluta-
mine encoding sequences were excised from the pMK1
plasmids with BsaI and BsmBI resulting in compatible
ends that allowed the seamless insertion of Q-blocks of
different lengths behind the N17 motif (Figure 6A).
To study the aggregation kinetics of Poly-Q proteins in
vitro, we applied a widely used filter retardation assay,
which allows the detection and quantification of small
amounts of Poly-Q containing aggregates [5]. This assay
is based on the characteristic of Poly-Q fibrils to be inso-
luble in solutions containing 2% sodium dodecyl sulfate
(SDS). Such fibrils are specifically retained on a cellulose-
acetate filter, whereas the soluble monomeric species are
denatured by SDS and filtered through the membrane.
The captured aggregates can then be visualized by immu-
nodetection. For such experiments fusion constructs
were commonly used carrying a N-terminal glutathione
S-transferase (GST) domain fused to the first exon of htt
via a factor Xa cleavage site [5]. In these constructs the
globular GST domain prevents aggregation of the mono-
mers. However, aggregation can be induced by release of
the GST moiety upon proteolytic factor Xa cleavage.
Based on this principle we designed a new construct in
which the first exon of the htt gene was fused to a
A
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Figure 6 Cloning and analysis of the final Poly-Q constructs.( A) The final constructs encode an N-terminal His6-tag (pink) and a SUMO-
domain (blue) followed by the 17 N-terminal amino acids of Huntingtin (N17, orange). The different Poly-Q encoding sequences (red) and a
FLAG-tag (yellow) are located at the 3’ end. Expression is controlled by a T7 promoter (brown). For cloning of the final constructs the Poly-Q
encoding repeats of different lengths were excised from of the pMK1-Qn vectors using BsaI and BsmBI. The resulting fragments were inserted
into pLANA, which was linearized with BsaI. The restriction sites were arranged in a way that allowed the seamless ligation of the Poly-Q
encoding sequences behind N17 into pLANA. Our final constructs still contain a BsaI site behind the Poly-Q encoding region allowing further
nucleotide insertions. Used restriction sites are underlined. (B) Three different constructs were successfully produced in E. coli and purified. The
proteins consisting of His6-SUMO-N17-Qn-FLAG were applied to SDS-PAGE and visualized by immunoblotting against the FLAG-tag. (C) Purified
His6-SUMO-N17-Q47-FLAG fusion proteins were treated with Ulp1 for 1 min and analyzed by SDS-PAGE and a-FLAG immunoblotting. (D) Filter
retardation assay using His6-SUMO-N17-Q47-FLAG fusion proteins. Membrane bound Poly-Q fibrils were visualized by a-FLAG immunodetection.
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an N-terminal His6-tag for affinity purification (Figure
6A). Importantly, the His6-SUMO domain keeps the pur-
ified Poly-Q containing fusion proteins soluble and
allows for the controlled induction of aggregation by
treatment with the Ulp1 protease (SUMO protease from
S. cerevisiae), which cleaves behind the two conserved
C-terminal glycine residues of folded SUMO [21].
Using the His6-SUMO fusion strategy the Poly-Q
proteins can be easily affinity purified under denaturing
conditions using silica-based Ni
2+-matrices (Figure 6B). As
Poly-Q proteins often tend to form insoluble inclusions
when expressed in E. coli, we purified our constructs under
denaturing conditions using 6 M guanidine hydrochloride
and refolded them on the affinity matrix by slowly decreas-
ing the concentration of the denaturant. The efficiency of
the refolding process was monitored by digestion of
the purified and soluble Poly-Q fusion proteins with Ulp1
(Figure 6C). Importantly, this protease does not recognize
a specific amino acid sequence but rather the native struc-
ture of the SUMO-domain. Under our experimental condi-
tions the purified fusion proteins were almost completely
digested by Ulp1 within one minute, indicating that refold-
ing of the constructs was successful. Therefore, we per-
formed the filter retardation assay with the Poly-Q fusion
proteins and induced aggregation by Ulp1 mediated clea-
vage. Figure 6D exemplifies the assay with our construct
containing 47 glutamine residues. In the control reaction,
where Ulp1 was omitted, no aggregation was observed
over six hours beyond marginal background signals. By
contrast, significant amounts of SDS-resistant Poly-Q
fibrils were formed after one hour upon induction of
SUMO cleavage. Accordingly, release of His6-SUMO from
the Poly-Q constructs occurs much faster than fibril for-
mation (Figure 6C and 6D). Thus, our His6-SUMO fusion
strategy provides a useful tool to study the kinetics of Poly-
Q aggregation in vitro.
Conclusion
As mentioned above, several other seamless cloning stra-
tegies were described previously, indicating the demand
for such methods. However, our approach has several
advantages compared to existing methods. Here we used
synthetic oligonucleotides to overcome the limitations of
PCR-based amplification of repetitive DNA sequences
and combined this strategy with seamless cloning using
Type IIS restriction enzymes. The usefulness of this
method was demonstrated by means of two frequently
occurring problems: the cloning of defined stretches of
Poly-Q encoding sequences and the generation of polya-
denine sequences for in vitro transcription of polyadeny-
lated mRNA. We chose the latter application because we
wanted to demonstrate that the technique is suitable for
generating fully homogenous nucleotide sequences of
defined length. Another important advantage is that our
method is directed. This means that in each elongation
cycle, the number of nucleotides added to the repetitive
sequence can be determined precisely by simply design-
ing the oligonucleotides accordingly. Importantly, a sin-
gle product is obtained in each step. Other methods
often generate a mixture of products due to multiple
insertions. Consequently, products of the right length or
sequence have to be selected or purified via agarose gels,
which makes the procedure more complicated, time-con-
suming, and error-prone. As we did not observe multiple
insertions and only rarely religations of the vector, this is
not necessary using our technique. In addition, the proto-
col presented here is straightforward. One round of elon-
gation can be done within one day, including restriction
digestion of the vector, ligation, and transformation. Bac-
terial growth and sequencing requires approximately two
further days. We obtained approximately 100-300 clones
per transformation and in most cases it was sufficient to
sequence a single clone. Moreover, combining pre-exist-
ing constructs can rapidly increase the length of the repe-
titive sequence (Figure 2 and 3). For example, once the
method was established, the pMK1-constructs could
be generated within three weeks including sequencing
(Figure 3A). We did not encounter a limitation of the
number of repeats for our purposes.
In general, our method is cheap because only the syn-
thetic oligonucleotides have to be purchased for each
application. We usually ordered 0.02 μmol of commer-
cially synthesized, HPLC-purified oligonucleotides, respec-
tively. The costs depend therefore on the list price per
nucleotide, purity, scale, and length of the oligonucleo-
tides. Once annealed and digested, the oligonucleotides
can be used for all subsequent elongation rounds and do
not have to be re-ordered. All other materials (e.g. restric-
tion enzymes, agarose gels, competent cells, DNA ligase)
are standard equipment for molecular cloning. It should
be mentioned that in principle the strategy could be used
also to assemble non-repetitive sequences. In this case, the
DNA fragments could be amplified even by PCR with pri-
mers carrying the Type IIS and Type IIP restriction sites
in the 5’ overhang regions. Finally, it should be also possi-
ble to fuse different repetitive sequences in a directed and
seamless manner (Figure 5).
In summary, our seamless cloning strategy is PCR-free
and allows the directed and efficient generation of highly
repetitive DNA sequences of defined lengths by simple
standard cloning techniques. Besides their applications in
basic research, as exemplified here, repetitive nucleotide
sequences become increasingly important in biopolymer
technology. As artificial proteins with unique physical
properties such as elastomeric polypeptides and synthetic
silk fibers often contain multiple amino acid repeats, new
strategies are required that improve the cloning of
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meric materials in biological systems [22,23]. The method
presented here is both, cheap and fast, and can be easily
adapted to produce any desired DNA sequences for a wide
range of applications.
Methods
Cloning Methods
All cloning steps were performed according to standard
protocols [24]. Restriction enzymes were named accord-
ing to [25]. HPLC-purified synthetic Q-block (5’-
ccagtgGGTCTCaCAGCAACAGCAACAGCAGCAGC
AACAGCAGcagagacgGAG CTCgatc-3’ and 5’-gatc-
GAGCTCcgtctctgCTGCTGTTGCTGCTGCTGTTGCT-
GTT GCTGtGAGACCcactgg-3’)a n dp o l y ( A )
oligonucleotides A31 (5’-gccgAAGCTT aaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaGAGACCcactgg-3’ and 5’-ccagtgGG
TCTCtttttttttttttttttttttttttt tttttAAGCTTcggc-3’) and A32
(5’-ccagtgGGTCTCAaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaA-
GAGACG acagCTCGAGgccg-3’ and 5’-cggcCTCGAGc
tgtCGTCTCTttttttttttttttttttttttttttttttTGAGACCcactgg-
3’) were obtained from Thermo Fisher Scientific. For
annealing 10 pmol of the antiparallel oligonucleotides
were mixed in a final volume of 100 μl. The reaction mix-
ture was heated up to 95°C for 5 min, incubated for 10
min at 55°C, and finally cooled down to room tempera-
ture. The annealed oligonucleotides were digested with
the respective restriction endonucleases (NEB) according
to the manufacturers protocol. Next, the DNA was preci-
pitated by addition of 1/10 volume 3 M sodium acetate
pH 5.2, 2.5 volumes of 100% (v/v) ethanol (p.a.) and incu-
bation at -20°C for at least 12 h. The DNA was recovered
by centrifugation at 16000 × g for 30 min at 4°C and the
DNA pellets were washed with 70% (v/v) ethanol. The
DNA pellets were dried at room temperature and subse-
quently resuspended in 100 μl sterile water. Aliquots of
the double-stranded digested oligonucleotides were
stored at -20°C and used for the subsequent cloning
cycles to elongate the repetitive sequences. Between 0.1
μla n d5μl of the digested oligonucleotides were ligated
with 30-70 ng linearized and dephosphorylated plasmid
DNA and T4 DNA ligase (Fermentas) in a 20 μl reaction
mixture according the manufacturers instructions. The
ligations were carried out at 23°C for 2 h and trans-
formed into 100 μlR b C l 2-competent E. coli cells (strain:
DH5aZ1). Plasmid preparation, gel extraction, and DNA
purification kits were obtained from Qiagen. All DNA
fragments originating from plasmid DNA were separated
by agarose gel electrophoresis and extracted using the
QIAquick Gel Extraction Kit (Qiagen). All plasmids gen-
erated during this study were verified by DNA sequen-
cing (GATC, Germany).
To generate the poly(A) constructs the protocol was
adapted due to the lower melting temperature of the poly
(A) oligonucleotides. The antiparallel oligonucleotides
were mixed as described above, heated to 95°C, and
annealed by a continuous temperature gradient of 0.1°C
per second to 4°C. To avoid any denaturation of poly(A)
stretches the annealed oligonucleotides as well as vectors
containing poly(A) regions were digested with the Type
IIS restriction enzymes overnight at 37°C. Restriction
enzymes were removed by phenol/chloroform extraction
according to standard protocols and the DNA was recov-
ered by ethanol precipitation as described above. The
resulting poly(A) constructs were analyzed by restriction
digestions and the lengths of the poly(A) stretches up to
100 base pairs could be determined precisely by sequen-
cing (GATC, Germany).
Expression and purification of Poly-Q proteins
The pLANA-Qn constructs (Figure 6A) were transformed
into the E. coli strain BL21(DE3). A two liter LB-culture
was inoculated with 20 ml of a stationary overnight culture
and grown to an OD600 nm of 0.6-0.8 at 30°C. Expression
was induced by the addition of 1 mM isopropylthio b-D-
1-galactopyranoside (IPTG). After 5 h cells were harvested
by centrifugation and flash-frozen in liquid nitrogen. The
cell pellets were resuspended in lysis buffer (30 mM
HEPES-KOH pH7.4, 500 mM potassium acetate, 5 mM
magnesium chloride 5% (v/v) glycerol, 1 mM ß-mercap-
toethanol, 1 mM phenylmethylsulphonyl fluoride (PMSF),
1 × protease inhibitor cocktail (Roche)) and lysed by
French press. After centrifugation at 30000 × g for 30 min
at 4°C the pellet was resuspended in denaturation buffer 1
(6 M guanidine hydrochloride (GdnHCl), 30 mM HEPES-
KOH pH 7.4) and incubated with 2.5 g Ni-IDA silica
matrix (Protino; Macherey-Nagel) for 30 min at 4°C while
rotating. The matrix was washed twice with 40 ml dena-
turation buffer 1, twice with 40 ml denaturation buffer
2 (4 M GdnHCl, 30 mM HEPES-KOH pH 7.4), twice with
40 ml denaturation buffer 3 (2 M GdnHCl, 30 mM
HEPES-KOH pH 7.4), twice with 40 ml high salt buffer
(30 mM HEPES-KOH pH 7.4, 1 M potassium acetate,
5 mM magnesium chloride, 5% (v/v) glycerol, 1 mM
ß-mercaptoethanol), and finally four times with with 40
ml low salt buffer (30 mM HEPES-KOH pH 7.4, 50 mM
potassium acetate, 5 mM magnesium chloride, 5% (v/v)
glycerol, 1 mM ß-mercaptoethanol). Proteins were
eluted with four times 10 ml elution buffer (30 mM
HEPES-KOH pH 7,4, 50 mM potassium acetate, 5 mM
magnesium chloride, 5% (v/v) glycerol, 1 mM ß-mercap-
toethanol, 250 mM imidazole-HCl pH 8.0). The purest
fractions were dialyzed against 5 l low salt buffer for 3 h.
To avoid aggregation the purified proteins were diluted,
frozen in liquid nitrogen, and stored at -80°C. The purified
proteins were analyzed by SDS-PAGE and Coomassie
staining as well as immunoblotting using FLAG antibodies
(ANTI-FLAG, Sigma).
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The Q-containing fusion proteins were thawed on ice
and diluted with low salt buffer (30 mM HEPES-KOH
pH 7.4, 50 mM potassium acetate, 5 mM magnesium
chloride, 1 mM ß- mercaptoethanol, 10% (v/v) glycerol)
to a final concentration of 0.02 mg/ml. Insoluble material
was removed by centrifugation at 16000 × g for 5 min at
4°C. The supernatant was divided into two samples,
which were directly used for the filter retardation assay.
The SUMO protease was added to one of the samples to
a final concentration of 10 μg per mg substrate protein.
The control reaction contained BSA instead of protease.
The reactions were incubated at 22°C in a final volume of
350 μl. At the indicated time points 50 μl samples (1 μg
fusion protein) were taken and mixed 1:1 with stop solu-
tion (4% (w/v) SDS, 100 mM dithiothreitol) followed by
incubation at 95°C for 5 min. Under these conditions
monomeric Poly-Q proteins are denatured whereas Poly-
Q aggregates remain intact. Subsequently, the samples
were applied to a Dot-blot filtration unit and filtered
through a cellulose-acetate membrane (0.2 μmp o r es i z e )
equilibrated with 2% (w/v) SDS in TBS (100 mM Tris-
HCl pH 8.0, 150 mM sodium chloride). After washing
with 0.1% (w/v) SDS in TBS the membrane was blocked
in TBS-T (100 mM Tris-HCl pH 8.0, 150 mM sodium
chloride, 0.05% (v/v) Tween-20) containing 5% (w/v)
non-fat dried milk. The aggregates were detected by
immunoblotting using primary FLAG-antibodies and
alkaline-phosphatase coupled to anti-rabbit IgG (1:10000,
Sigma).
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